Literature DB >> 10328519

Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum.

H Lee1, F I Tarazi, M Chakos, H Wu, M Redmond, J M Alvir, B J Kinon, R Bilder, I Creese, J A Lieberman.   

Abstract

Human MRI studies have demonstrated that treatment with typical antipsychotics may increase the volume of the caudate nucleus while clozapine treatment is associated with either no change or a reversal of the previous volume increase. In this study four groups of seven rats were treated for 8 months with either the typical antipsychotic haloperidol, the atypical antipsychotic clozapine, the D2/D3 receptor antagonist raclopride, or vehicle (plain drinking water). Striatal sections were prepared using D1-like and D2-like receptor ligand autoradiography. Images (4-6 sections per rat, per ligand) were digitized and the area of the striatum was measured on each section. Rats treated with haloperidol did not have a larger mean striatum area than the control group on either D1- or D2-like ligand autoradiograms. Using the D2-like ligand autoradiograms, the clozapine treated animals had a smaller mean striatum area than the control group. Mean left striatum area was larger than mean right striatum area in each treatment group and in the control group. In contrast to the MRI findings reported in schizophrenia, the area of the striatum was not increased in rats treated with typical antipsychotic agents, but the clozapine-associated area reduction may parallel the clinical studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328519     DOI: 10.1016/s0024-3205(99)00106-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  Neuroimaging correlates of aggression in schizophrenia: an update.

Authors:  Matthew J Hoptman; Daniel Antonius
Journal:  Curr Opin Psychiatry       Date:  2011-03       Impact factor: 4.741

Review 2.  Antipsychotic drugs for first-episode schizophrenia: a comparative review.

Authors:  Kayvon Salimi; L Fredrik Jarskog; Jeffrey A Lieberman
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

3.  Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type.

Authors:  Robert K McClure; Martin Styner; Eric Maltbie; Jeffrey A Lieberman; Sylvain Gouttard; Guido Gerig; Xiaoyan Shi; Hongtu Zhu
Journal:  Psychiatry Res       Date:  2012-11-09       Impact factor: 3.222

4.  Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression.

Authors:  Jose Javier Miguel-Hidalgo; Priti Dubey; Qingmei Shao; Craig Stockmeier; Grazyna Rajkowska
Journal:  Schizophr Res       Date:  2005-07-15       Impact factor: 4.939

Review 5.  Morphological brain changes in depression: can antidepressants reverse them?

Authors:  José Javier Miguel-Hidalgo; Grazyna Rajkowska
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 6.  Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases.

Authors:  Thérèse M Jay; Cyril Rocher; Maïte Hotte; Laurent Naudon; Hirac Gurden; Michael Spedding
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

7.  Administration of ziprasidone for 10 days increases cocaine toxicity in mice.

Authors:  K Heard; S Krier; N R Zahniser
Journal:  Hum Exp Toxicol       Date:  2008-06       Impact factor: 2.903

8.  Impact cérébral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrénie : revue systématique des études longitudinales en neuroimagerie.

Authors:  Anaïs Vandevelde; Lucie Métivier; Sonia Dollfus
Journal:  Can J Psychiatry       Date:  2020-11-02       Impact factor: 4.356

Review 9.  Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review.

Authors:  B H Ebdrup; H Nørbak; S Borgwardt; B Glenthøj
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

10.  SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia.

Authors:  M Udawela; T T Money; J Neo; M S Seo; E Scarr; B Dean; I P Everall
Journal:  Transl Psychiatry       Date:  2015-08-04       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.